2021
Polyisocyanates and Their Prepolymers
Jolly A, Maestrelli P, Redlich C, Malo J, Bernstein D. Polyisocyanates and Their Prepolymers. 2021, 179-194. DOI: 10.1201/9781003000624-14.ChaptersOccupational asthmaHuman leukocyte antigenAirway inflammationDiisocyanate-induced occupational asthmaSensitizer-induced occupational asthmaWeight agentsOnset of asthmaOnset of symptomsLong-term outcomesMedical surveillance programNon-HLA genesReduction of exposureAverage exposure levelsAirway hyperresponsivenessSevere asthmaAsthmatic symptomsClinical presentationNeutrophilic infiltrateLeukocyte antigenClinical assessmentDifferent exposure metricsIrritant concentrationsHigh riskMechanism of sensitizationIsocyanate exposure
2011
An Official American Thoracic Society Statement: Work-Exacerbated Asthma
Henneberger PK, Redlich CA, Callahan DB, Harber P, Lemière C, Martin J, Tarlo SM, Vandenplas O, Torén K. An Official American Thoracic Society Statement: Work-Exacerbated Asthma. American Journal Of Respiratory And Critical Care Medicine 2011, 184: 368-378. PMID: 21804122, DOI: 10.1164/rccm.812011st.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsWork-exacerbated asthmaWork-related symptomsClinical characteristicsOccupational asthmaOfficial American Thoracic Society StatementAmerican Thoracic Society StatementWorsening of asthmaOnset of asthmaStandard medical managementMedical managementAdverse outcomesDescriptive epidemiologyOA casesRisk factorsAdverse socioeconomic outcomesCase definitionOccupational exposureSociety statementMedian prevalenceAsthmaWork exposurePreventive interventionsMedical careMedical literatureSystematic search